Badje, A., Moh, R., Gabillard, D., Guéhi, C., Kabran, M., Ntakpé, J., Carrou, J. L., Kouame, G. M., Ouattara, E., Messou, E., Anzian, A., Minga, A., Gnokoro, J., Gouesse, P., Emieme, A., Toni, T., Rabe, C., Sidibé, B., Nzunetu, G., Dohoun, L., Yao, A., Kamagate, S., Amon, S., Kouame, A., Koua, A., Kouamé, E., Daligou, M., Hawerlander, D., Ackoundzé, S., Koule, S., Séri, J., Ani, A., Dembélé, F., Koné, F., Oyebi, M., Mbakop, N., Makaila, O., Babatunde, C., Babatunde, N., Bleoué, G., Tchoutedjem, M., Kouadio, A., Sena, G., Yededji, S., Karcher, S., Rouzioux, C., Kouame, A., Assi, R., Bakayoko, A., Domoua, S. K., Deschamps, N., Aka, K., N'Dri-Yoman, T., Salamon, R., Journot, V., Ahibo, H., Ouassa, T., Menan, H., Inwoley, A., Danel, C., Eholié, S. P., Anglaret, X., & , (2017). effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Lancet, 5(11), e1080–e1089. http://access.bl.uk/ark:/81055/vdc_100050326810.0x000013